The Pharmacy Times® Hepatitis Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of a group of distinct diseases that cause inflammation of the liver, including hepatitis A, B, C, and D.
April 24th 2025
The investigators’ hypothesis is supported by phase 2 trial data in which hydronidone resulted in significant reversal of liver fibrosis in patients with chronic hepatitis B (CHB).
Counseling Patients with the Difficult Diagnosis of Hepatitis C
February 15th 2010Hepatitis C can be a challenging disease for patients. Pharmacists can be instrumental in educating their patients about the pharmacologic agents available for treatment and provide them with valuable resources to successfully manage this condition.
Read More